Ewing, NJ, United States of America

William David Steber



Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 192(Granted Patents)


Location History:

  • Ledgewood, NJ (US) (1989 - 2002)
  • Ewing, NJ (US) (1998 - 2003)

Company Filing History:


Years Active: 1989-2003

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of William David Steber

Introduction

William David Steber, residing in Ewing, NJ, is a distinguished inventor with a strong focus on advancements in parenteral therapeutic compositions. With a remarkable portfolio of eight patents, his contributions significantly enhance the field of pharmaceuticals, particularly in treatments for parasitic infections in warm-blooded animals.

Latest Patents

Steber's latest patents showcase his innovative approach to sustained-release formulations. One prominent patent is for "Sustained-release compositions for parenteral administration," which involves a composition comprising a macrolide compound, a surfactant, a co-solvent, and a solvent. This invention allows for parenteral administration and effectively prevents or treats various parasitic infections or infestations in animals over extended periods.

Another notable patent is titled "Stable compositions for parenteral administration and their use." This invention details stable microsphere compositions that include a fat, a wax, and active ingredients such as LL-F28249α-λ compounds. The invention aims to introduce and maintain therapeutic levels of active compounds in the bloodstream of warm-blooded animals, providing a long-term solution against infections caused by helminths and other parasites.

Career Highlights

Throughout his career, William David Steber has made significant impacts while working with reputable organizations. He has been associated with American Cyanamid Company and SmithKline Beecham Corporation, where he contributed his expertise in pharmaceutical innovations. His work has played a crucial role in fostering advancements that benefit both the animal health sector and the broader pharmaceutical industry.

Collaborations

Steber has collaborated with notable colleagues, including Susan Mancini Cady and Lilian Kwan. These collaborations have enriched his research and development efforts, leading to breakthroughs in stable parenteral compositions and innovative treatment methods for parasitic infections.

Conclusion

William David Steber's contributions to the field of veterinary medicine through his patents illustrate the vital role of innovation in addressing health challenges. His continuous efforts exemplify dedication to improving treatment modalities for parasitic infections, reinforcing the importance of research and collaboration in the development of effective therapeutic solutions. As he progresses in his career, Steber remains a respected figure among inventors and a beacon of advancement in pharmaceutical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…